View in EDS HTML Full Text PDF Full Text

Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease.

Saved in:
Bibliographic Details
Title: Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease.
Authors: Layton, J. Bradley1 (AUTHOR), Ziemiecki, Ryan1 (AUTHOR), Johannes, Catherine B.2 (AUTHOR), Pladevall-Vila, Manel3,4 (AUTHOR), Khan, Anam M.2 (AUTHOR), Ebert, Natalie5 (AUTHOR), Kovesdy, Csaba P.6 (AUTHOR), Christiansen, Christian Fynbo7 (AUTHOR), García-Sempere, Aníbal8 (AUTHOR), Kanegae, Hiroshi9 (AUTHOR), Coleman, Craig I.10,11 (AUTHOR), Walsh, Michael12 (AUTHOR), Andersen, Ina Trolle7 (AUTHOR), Rodríguez-Bernal, Clara8 (AUTHOR), Cabaniñas, Celia Robles8 (AUTHOR), Thomsen, Reimar W.7 (AUTHOR), Farjat, Alfredo E.13 (AUTHOR), Gay, Alain13 (AUTHOR), Gee, Patrick14 (AUTHOR), Hurtado, Isabel8 (AUTHOR)
Source: Diabetes Therapy. Aug2025, Vol. 16 Issue 8, p1597-1614. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:18696953
DOI:10.1007/s13300-025-01750-7